- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 14, 2026 | 7.42M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 14.51M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 14.51M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 14.17M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 14.17M sh |
| Capex | Q3 2026 · Mar 31, 2026 | $4.42K |
| Capex | Q3 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$151.42K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $364.97K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $3.34M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $545.84K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $540.91K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2024 | $209.03K |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $4.15M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $1.77M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $1.92M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $2.29M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $2.02M |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | $1.81M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $2.53M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $2.69M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $3.39M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $3.08M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $6.57M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $4.61M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $7.53M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $4.99M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.16 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.15 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.02 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.03 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.16 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.15 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.02 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.03 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $1.34M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $3.77M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $1.16M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $3.42M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $29.91K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $377.19K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $164.76K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $461.55K |
| Net Income | Q3 2026 · Mar 31, 2026 | $2.37M |
| Net Income | Q3 2026 · Mar 31, 2026 | $2.23M |
| Net Income | Q3 2026 · Dec 31, 2025 | $97.68K |
| Net Income | Q3 2026 · Mar 31, 2025 | $271.47K |
| Net Income | Q3 2026 · Mar 31, 2025 | $485.28K |
| Net Income | Q3 2026 · Dec 31, 2024 | $246.02K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$419.26K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$523.28K |
| Operating Income | Q3 2026 · Mar 31, 2025 | $276.04K |
| Operating Income | Q3 2026 · Mar 31, 2025 | $504.99K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.66M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $5.25M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.87M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $5.09M |